ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
Yu ZZ, Liu YY, Zhu W, Xiao D, Huang W, Lu SS, Yi H, Zeng T, Feng XP, Yuan L, Qiu JY, Wu D, Wen Q, Zhou JH, Zhuang W, Xiao ZQ.
Yu ZZ, et al. Among authors: wu d.
J Immunother Cancer. 2023 Mar;11(3):e006345. doi: 10.1136/jitc-2022-006345.
J Immunother Cancer. 2023.
PMID: 37001908
Free PMC article.